Tweet from EricTopol at March 20, 2023 at 03:10PM
A randomized trial of a blood thinner after severe Covid to prevent clothing events. Summary of result: “highly compatible with estimates of efficacy ranging from a 56% reduction to a 95% increase risk of apixiban compared with placebo
https://t.co/SqsS7OCwKq @AnnalsofIM https://t.co/mZCcbXwKBf— Eric Topol (@EricTopol)
Mar 20, 2023
from http://twitter.com/EricTopol